Bi, W., Xu, W., Cheng, L., Xue, J., Wang, Q., Yu, F., . . . Jiang, S. (2019). IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies. PLoS Pathog.
Chicago-stil citatBi, Wenwen, et al. "IgG Fc-binding Motif-conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-life: Potential Application in Combination With Broad Neutralizing Antibodies." PLoS Pathog 2019.
MLA-referensBi, Wenwen, et al. "IgG Fc-binding Motif-conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-life: Potential Application in Combination With Broad Neutralizing Antibodies." PLoS Pathog 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.